Myeloproliferative Neoplasms News

In this video, John O. Mascarenhas, MD, highlighted a presentation that explored the science driving clinical development.

John O. Mascarenhas, MD, spoke with Healio about a presentation given during the morning session at 14th International Congress on Myeloproliferative Neoplasms.

Early referral to transplantation can increase access to transplant and cell therapies, as well as improve outcomes among patients with hematologic malignancies, according to a speaker at Chemotherapy Foundation Symposium.

In this video, John O. Mascarenhas, MD, provided an overview of his presentation at 14th International Congress on Myeloproliferative Neoplasms that delved into new treatments, specifically focused on myelofibrosis.

Luspatercept-aamt improved red blood cell transfusion independence with a concurrent hemoglobin increase among certain patients with myelodysplastic syndrome, according to the agent’s manufacturer.

Four individuals have been elected to American Society of Hematology’s executive committee.

The investigational therapy GB2064 reduced fibrosis in the bone marrow of patients with myelofibrosis, according to results of a phase 2A study released by the agent’s manufacturer.

Anxiety and depression that may follow a cancer diagnosis, especially as a patient approaches the end of life, can be incapacitating and difficult to assuage.

It is well known that obesity, physical inactivity and a poor diet increase the risk for various cancer types and contribute to adverse outcomes among adults with certain malignancies.

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.